ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea · Delayed Price · Currency is KRW 90,000
-1,800 (-1.96%)
Sep 11, 2026, 3:30 PM KST
ST Pharm Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,878,897 | 2,467,641 | 1,790,029 | 1,275,235 | 1,647,649 | 2,596,915 | |
Market Cap Growth | -0.50% | 37.85% | 40.37% | -22.60% | -36.55% | 34.10% |
Enterprise Value | 1,782,866 | 2,427,616 | 1,811,053 | 1,375,695 | 1,714,024 | 2,628,966 |
Last Close Price | 90000.00 | 118825.86 | 88620.97 | 67198.76 | 86117.30 | 136081.99 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 24.70 | 44.87 | 51.57 | 65.13 | 91.54 | 784.06 |
Forward PE | 23.45 | 39.88 | 36.22 | 37.69 | 67.19 | 133.19 |
PS Ratio | 4.86 | 7.44 | 6.54 | 4.47 | 6.61 | 15.68 |
PB Ratio | 2.99 | 4.16 | 3.56 | 3.30 | 4.83 | 7.97 |
P/TBV Ratio | 3.07 | 4.28 | 3.68 | 3.44 | 5.07 | 8.37 |
P/FCF Ratio | 24.31 | - | 67.18 | - | - | - |
P/OCF Ratio | 16.68 | 176.40 | 16.36 | 982.17 | 234.34 | 357.22 |
PEG Ratio | 0.76 | 0.96 | 0.62 | 0.74 | 0.48 | 4.96 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.61 | 7.32 | 6.62 | 4.83 | 6.88 | 15.87 |
EV/EBITDA Ratio | 17.04 | 28.62 | 33.99 | 24.33 | 48.35 | 131.50 |
EV/EBIT Ratio | 25.17 | 44.19 | 65.40 | 41.05 | 96.02 | 471.35 |
EV/FCF Ratio | 23.07 | - | 67.97 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.12 | 0.13 | 0.24 | 0.50 | 0.39 | 0.33 |
Debt / EBITDA Ratio | 0.72 | 0.93 | 2.22 | 3.40 | 3.79 | 5.38 |
Debt / FCF Ratio | 0.97 | - | 4.43 | - | - | - |
Net Debt / Equity Ratio | -0.15 | -0.02 | -0.01 | 0.26 | 0.25 | 0.04 |
Net Debt / EBITDA Ratio | -0.91 | -0.14 | -0.05 | 1.80 | 2.38 | 0.72 |
Net Debt / FCF Ratio | -1.24 | 0.37 | -0.10 | -2.43 | -1.58 | -0.32 |
Asset Turnover | 0.49 | 0.44 | 0.39 | 0.46 | 0.47 | 0.35 |
Inventory Turnover | 1.31 | 1.34 | 1.46 | 1.54 | 1.72 | 1.75 |
Quick Ratio | 1.11 | 1.15 | 1.43 | 2.53 | 0.82 | 3.00 |
Current Ratio | 2.28 | 2.26 | 2.48 | 4.16 | 1.47 | 4.64 |
Return on Equity (ROE) | 13.61% | 9.96% | 7.30% | 4.81% | 5.25% | 1.08% |
Return on Assets (ROA) | 5.60% | 4.56% | 2.48% | 3.36% | 2.09% | 0.74% |
Return on Invested Capital (ROIC) | 12.40% | 9.44% | 4.25% | 5.50% | 4.25% | 1.79% |
Return on Capital Employed (ROCE) | 10.90% | 8.90% | 4.70% | 5.70% | 4.60% | 1.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.09% | 2.23% | 1.94% | 1.54% | 1.09% | 0.13% |
FCF Yield | 4.11% | -1.34% | 1.49% | -3.29% | -3.24% | -1.71% |
Dividend Yield | 0.49% | 0.42% | - | - | - | - |
Payout Ratio | 13.72% | 18.32% | 27.09% | 48.03% | 52.25% | - |
Buyback Yield / Dilution | -9.11% | -9.95% | -3.70% | - | -0.77% | -0.05% |
Total Shareholder Return | -8.62% | -9.53% | -3.70% | - | -0.77% | -0.05% |